AlphaMadera combines institutional-grade analytics, real-time market data, and AI research tools to help investors make smarter long-term decisions.
Explore the Platform →Built for investors who think in decades, not days.
To our valued customers, log in here >
Former Goldman Sachs CEO Lloyd Blankfein has warned that the growing private credit market could lead to a financial crisis similar to the one in 2008, potentially affecting retail investors and the broader economy. In an interview on Bloomberg's “Big Take” podcast, the renowned moneyman said the $1.
Wall Street's “fear gauge” was rising on Tuesday as the S&P 500 and other major U.S. equity indexes touched their lowest levels of the year, before an afternoon rebound caused them to recoup much of their earlier losses.
The Federal Reserve has separated into two distinct wings on whether to cut U.S. interest rates this year — and the so-called doves appear to be gaining ascendancy over the so-called hawks.
AI is now a core capital expenditure supercycle, reshaping industries and driving unprecedented investment in chips, cybersecurity, and defense technology. Recent Pentagon actions and aggressive AI mandates underscore surging, underappreciated demand for AI in defense and national security.
Ariel Investments co-CEO John Rogers says he does see the risk of a small recession on the horizon in the US because so many Americans are struggling. He speaks to Bloomberg Television at Bloomberg Invest.
The Investment Committee debate the volatility in the market and how you should trade it.
Conflict-related betting on prediction markets hit a record last week as traders piled into wagers on the US-Israeli strikes on Iran, while blockchain analysts flagged suspicious activity and lawmakers called for a crackdown. Yesha Yadav, professor of law and associate dean at Vanderbilt Law School, joins Isabelle Lee and Tim Stenovec on "Bloomberg Crypto," to discuss the need for regulatory prediction market guardrails in the US.
The clean energy sector has generally outperformed the broader stock index, with the benchmark S&P Global Clean Energy Transition Index returning 63% over the past year. That easily outpaced the S&P 500, which is up 15.5% over the same timeframe.
Trump raised the possibility during an Oval Office meeting with German Chancellor Friedrich Merz.
Financial markets are now pricing in months of higher gasoline prices, and panic is spreading.
UK Chancellor of the Exchequer Rachel Reeves sits down with Bloomberg's Stephanie Flanders after delivering her budget outlook in the government's Spring Statement. They talk about the economy, the war in Iran and finalizing a trade deal with the US.
The NASDAQ fell three percent in February, the tech-heavy index's worst monthly performance since March 2025. The private credit markets and a war in Iran are two new worries for investors that emerged in February.
Federal Reserve Bank of Minneapolis President Neel Kashkari examines the potential inflation impact on the United States from the war with Iran and what it could mean for monetary policy. He speaks on the sidelines of Bloomberg Invest.
Minneapolis Fed President Neel Kashkari said that he expects one rate cut later this year, but needs to examine further data to assess if that stance is appropriate due to recent geopolitical events.
A top Federal Reserve official said he sees an increasing divide between low-income and high-income households.
The U.S. Treasury Department and bank regulators are eyeing a comprehensive review of bank liquidity rules, arguing existing rules are ineffective and impede lending.
Investors' sky-high hopes for technology companies are being met these days by a far more earthbound reality.
After a subdued day of market action on Monday as investors digested the rising conflict in the Middle East, Tuesday brought a different tone.
Rising oil prices driven by the US-Iran war threaten to trigger a secondary inflation wave, reminiscent of the 1978 scenario. Core CPI is at a critical inflection point, with energy price shocks likely to push inflation higher in the coming months.
"This will be a shakeout. I don't think it is going to be short term," Marc Rowan, CEO and co-founder of Apollo Global Management, says during a discussion with Bloomberg News Editor-in-Chief John Micklethwait at Bloomberg Invest.
EVgo, Inc. (EVGO) Q4 2025 Earnings Call Transcript
ATLANTA, GA / ACCESS Newswire / March 3, 2026 / HAVERTY FURNITURE COMPANIES, INC. (NYSE:HVT, HVT.A) announced today that Steven G.
FY 2025 revenue increased to $176.2 million, exceeding the high end of previous guidance Life Sciences Services revenue grew 18% year-over-year in FY 2025, including a 22% rise in BioStorage/BioServices revenue Commercial cell and gene therapy revenue increased 29% year-over-year to $33.4 million in FY 2025 Supported a record 760 global clinical trials and 20 commercially approved therapies as of December 31, 2025 Full-year 2026 revenue guidance of $190 million to $194 million (8%-10% growth y-o-y) NASHVILLE, Tenn., March 3, 2026 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, today announced financial results for its fourth quarter (Q4) and year ended (FY) December 31, 2025.
Delivered 9th consecutive year of profitability with net income of $76.7 million , or 10.8% margin
TACOMA, Wash.--(BUSINESS WIRE)--TrueBlue, Inc. (NYSE: TBI) (“TrueBlue” or the “Company”) today issued the following statement in response to the recent statements made by EHS Investments (“EHS”): On February 18, 2026, TrueBlue reported its second consecutive quarter of organic revenue growth and detailed plans to continue improving profitability, lowering operating costs and building a more focused and agile organization. Those plans are progressing and we are confident they will lead to signif.
PARSIPPANY, N.J.--(BUSINESS WIRE)--B&G Foods, Inc. (NYSE: BGS) today announced financial results for the fourth quarter and full year 2025. Financial results for the fourth quarter and full year 2025 include the impact of the Don Pepino divestiture during the second quarter of 2025, the Le Sueur U.S. divestiture during the third quarter of 2025, and an extra reporting week in the fourth quarter and full year 2025 as compared to the fourth quarter and full year 2024. Summary Fourth Quart.
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced its financial results for the fourth quarter and full-year ended December 31, 2025. “In 2025 we generated nearly $300 million in total net revenue delivering our sixth consecutive year of double-digit growth,” said David Moatazedi, President and Chief Executive Officer of Evolus. “Our performance beauty posit.
NEW YORK and WALTHAM, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced that it granted equity awards on March 2, 2026, to three newly-hired, non-executive employees. The inducement grants were approved by the Company's independent Compensation Committee and were made as material inducements to acceptance of employment with Dianthus in accordance with Nasdaq Listing Rule 5635(c)(4).
NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the Compensation Committee of the Company's Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 32,450 shares of the Company's common stock to four new employees (the “Inducement Grants”) on March 2, 2026 (the “Grant Date”). The Inducem.
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Northrim BanCorp, Inc. (“Northrim” or the “Company”) (NASDAQ: NRIM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.